Office of National Drug Control Policy COVID-19 Fact Sheet
Office of National Drug Control Policy (ONDCP)
Summarizes policy changes made by federal National Drug Control Program agencies in response to the COVID-19 pandemic. Outlines program and policy changes designed to ensure individuals with substance use disorders (SUDs) can continue to safely access important treatment and recovery support services during the pandemic. Addresses several priority areas, including guidance for prevention, treatment, and recovery services; use of telemedicine and electronic prescribing, flexibility for methadone and buprenorphine treatment, access to prescribed controlled substances, support for rural and tribal communities; and relief opportunities for individuals, providers, and small businesses. Provides links to programs and agencies for additional details related to specific policy changes.
COVID-19 Response • Medication-Assisted Treatment (MAT) • Naloxone • Opioids • Overdose Prevention • Pain Management and Opioid Prescribing • Policy • Prevention • Recovery • Substance Use Disorder • Syringe Services Programs • Teleservices and Technology • Treatment